Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 6;11(7):1907.
doi: 10.3390/biomedicines11071907.

Therapeutic Potential of EVs: Targeting Cardiovascular Diseases

Affiliations
Review

Therapeutic Potential of EVs: Targeting Cardiovascular Diseases

Javier Laura Francés et al. Biomedicines. .

Abstract

Due to their different biological functions, extracellular vesicles (EVs) have great potential from a therapeutic point of view. They are released by all cell types, carrying and delivering different kinds of biologically functional cargo. Under pathological events, cells can increase their secretion of EVs and can release different amounts of cargo, thus making EVs great biomarkers as indicators of pathological progression. Moreover, EVs are also known to be able to transport and deliver cargo to different recipient cells, having an important role in cellular communication. Interestingly, EVs have recently been explored as biological alternatives for the delivery of therapeutics, being considered natural drug delivery carriers. Because cardiovascular disorders (CVDs) are the leading cause of death worldwide, in this review, we will discuss the up-to-date knowledge regarding the biophysical properties and biological components of EVs, focusing on myocardial infarction, diabetic cardiomyopathy, and sepsis-induced cardiomyopathy, three very different types of CVDs.

Keywords: EVs; cardiovascular diseases; diabetic cardiomyopathy; exosomes; extracellular vesicles; myocardial infarction; septic-induced cardiomyopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of cell-to-cell communication in myocardial infarction through extracellular vesicles.
Figure 2
Figure 2
Summary of cell-to-cell communication in diabetic cardiomyopathy through extracellular vesicles.
Figure 3
Figure 3
Summary of cell-to-cell communication in sepsis-induced cardiomyopathy through extracellular vesicles.

Similar articles

Cited by

References

    1. Patil M., Henderson J., Luong H., Annamalai D., Sreejit G., Krishnamurthy P. The Art of Intercellular Wireless Communications: Exosomes in Heart Disease and Therapy. Front. Cell Dev. Biol. 2019;7:315. doi: 10.3389/fcell.2019.00315. - DOI - PMC - PubMed
    1. Fu S., Zhang Y., Li Y., Luo L., Zhao Y., Yao Y. Extracellular vesicles in cardiovascular diseases. Cell Death Discov. 2020;6:68. doi: 10.1038/s41420-020-00305-y. - DOI - PMC - PubMed
    1. Jadli A.S., Parasor A., Gomes K.P., Shandilya R., Patel V.B. Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger. Front. Cardiovasc. Med. 2021;8:767488. doi: 10.3389/fcvm.2021.767488. - DOI - PMC - PubMed
    1. Sluijter J.P.G., Verhage V., Deddens J.C., Van Den Akker F., Doevendans P.A. Microvesicles and exosomes for intracardiac communication. Cardiovasc. Res. 2014;102:302–311. doi: 10.1093/cvr/cvu022. - DOI - PubMed
    1. Yuan M.J., Maghsoudi T., Wang T. Exosomes mediate the intercellular communication after myocardial infarction. Int. J. Med. Sci. 2016;13:113–116. doi: 10.7150/ijms.14112. - DOI - PMC - PubMed

LinkOut - more resources